NCEL NCEL
Company Profile ↓Company Overview
NCEL (NCEL) is a publicly traded company listed on with a market capitalization of $17.08M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Growth & Price Performance
Stock Price Performance
| 1 Year: | -81.16% |
| 6 Months: | +30.40% |
| 3 Months: | -0.84% |
| 1 Month: | -11.22% |
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)47.00 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
No notable strengths flagged.
CONS
- Trading 87.2% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | - | 0 | 0 | 0 | 0 |
| Cost of Revenue | - | - | - | - | - |
| Gross Profit | 0 | 0 | 0 | 0 | - |
| Operating Expenses | - | 6.25M | 3.02M | 1.80M | 2.47M |
| Operating Income | - | -6.25M | -3.02M | -1.80M | -2.47M |
| EBITDA | - | -5.87M | -2.47M | -1.74M | -2.24M |
| Interest Expense | - | 78.04K | 239.00K | 5.04M | 6.01M |
| Pretax Income | - | -6.49M | -3.33M | -7.20M | -8.30M |
| Tax Provision | -142.57K | -47.39K | -52.68K | -8.21K | - |
| Net Income | - | -6.45M | -3.33M | -7.20M | -8.30M |
| Diluted EPS | - | -2.59 | -1.13 | -2.43 | -2.16 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 3.54M | 2.20M | 903.00K | 11.45M |
| Current Assets | - | 2.10M | 1.53M | 780.00K | 3.18M |
| Cash & Equivalents | - | 1.81M | 1.09M | 650.00K | 2.20M |
| Inventory | - | - | - | - | - |
| Receivables | 219.48K | - | - | - | - |
| Total Liabilities | - | 3.45M | 3.35M | 8.90M | 4.20M |
| Current Liabilities | - | 2.99M | 3.35M | 8.90M | 4.20M |
| Long Term Debt | - | 0 | 834.00K | - | - |
| Total Debt | - | 2.02M | 2.62M | 2.67M | 355.00K |
| Total Equity | - | 92.51K | -1.15M | -8.00M | 7.25M |
| Shares Outstanding | - | 2.57M | 2.96M | 2.96M | 4.80M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | -5.67M | -3.44M | -1.07M | -2.77M |
| Investing Cash Flow | - | -186.15K | 103.00K | -6.00K | 1.70M |
| Financing Cash Flow | - | 1.06M | 2.85M | 450.00K | 2.63M |
| Capital Expenditure | - | -181.61K | -6.00K | -6.00K | -8.00K |
| Free Cash Flow | - | -5.86M | -3.45M | -1.07M | -2.77M |
| Net Change in Cash | - | -4.80M | -492.00K | -622.00K | 1.56M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - |
| Operating Margin % | - | - | - | - | - |
| Net Margin % | - | - | - | - | - |
| ROE % | - | -6,968.7% | 290.1% | 90.0% | -114.5% |
| ROCE % | - | -1,125.8% | 263.7% | 22.5% | -34.1% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for NCEL
NewcelX Announces $1.4 Million Private Placement at 20% Premium to Market to Advance NCEL-101 for Type 1 Diabetes - Quiver Quantitative
<a href="https://news.google.com/rss/articles/CBMi5AFBVV95cUxQa2JnV3h0Zi0xUE1MS1FQc18tdGRXU1ZoeHV5Ri16a0hUMFNXNzRCV0I0dUNIUlFIRXJVQmFTeU9TTHFCQUxqZGo1WXJCblZnMEpRSmZFaWJ1U0d1M0ZoNTEydWRmRElxc0k5MWtZQnNtbmtOUEktRnVqbjd1UHowR19vbHh5TERYY1NoQ2…
symbol__ Stock Quote Price and Forecast - CNN
<a href="https://news.google.com/rss/articles/CBMiUEFVX3lxTFA3bktRUDZjN2g4X1pTOGNQampXMVdUbFh6QkhVQmE1Z2dvOHNyb0wzSzVhNTEzLTd3OU9zV3Utb1VkZVhGVU5xT19WZk5PS2pO?oc=5" target="_blank">symbol__ Stock Quote Price and Forecast</a> <fon…
NewcelX (NCEL) Announces Private Placement at 20% Premium Amid U - GuruFocus
<a href="https://news.google.com/rss/articles/CBMiugFBVV95cUxNNldvTG5LZmxaVVVYMWJNYUZCa0NfSV9YcVdnZ0E2X3JMaDJQSERIVFFRem9LM0gtMlM5ZVpidUhvWU5ra2MzUXQ1V2piMWdxeFpubG9tLWJnM3E3blhvOEZRLTB2TXA5d0lSbm1vSUkwMGlmQVo5cWxKZ3hxNm1JRHMzZEVoM3VuSUJ3bF…
NCEL: NewcelX Ltd. - Price & Consenus Chart - Zacks Investment Research
<a href="https://news.google.com/rss/articles/CBMibEFVX3lxTFBTeldHMzE3TkZCeU51Ukk1T3o4b1FHQ3RkeGZpNF9FNkQyWEpVSjdVU0stV204UFpUb1MtRW9IelZyc1RuS1B5V1lGZFZPVEJuTTlyQUc5TnVjbGNzUGFRUFZkcE0tbnRJUGZORQ?oc=5" target="_blank">NCEL: NewcelX Ltd. - …
NCEL Should I Buy - Intellectia AI
<a href="https://news.google.com/rss/articles/CBMiXkFVX3lxTE9yamdDYjRUNmF0Z0RGU2xtdEJIcGxUY3RjaGpfOEJ6WVVJYWlSaWpZQ2hjNGlQaG9HMFJSeEtsM05vTEFJMWJ3RDFPekZ0R0JnZWJ5SDQyN2RtR2E3Z3c?oc=5" target="_blank">NCEL Should I Buy</a> <font c…
NewcelX Ltd. Revenue Breakdown – NASDAQ:NCEL - TradingView
<a href="https://news.google.com/rss/articles/CBMid0FVX3lxTE9DTmx2UmhZTFBIZTE1MFpYNjhkVHVJbUNDRGJQR04xM2UtMnZHT3RVczBlc0RmT01QUkdTYmhvU3FQcTA4WWhua29iZ0l0eFgzd2ZIWGowT3MwNFF0VU5hbFV2X3U5ck9FTW14V2Ita3JGOWJRWktv?oc=5" target="_blank">NewcelX…
NCEL — Frequently Asked Questions
What is the current share price of NCEL?
As of 2026-08-05 17:25 PDT, NCEL trades at $3.56 on NASDAQ/NYSE. Its 52-week range is $1.88 to $27.90.
What is the market capitalisation of NCEL?
NCEL has a market capitalisation of $17.08M on NASDAQ/NYSE.
What is the P/E ratio of NCEL?
NCEL trades at a trailing price-to-earnings (P/E) ratio of -1.65. Its price-to-book (P/B) ratio is 2.36.
What is the return on equity (ROE) of NCEL?
NCEL has a return on equity (ROE) of -114.48%. Its return on capital employed (ROCE) is -34.12%.
Is NCEL a good stock to buy?
This page provides a data-driven analysis of NCEL, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.